IMMUNOVANT, INC. Non Peo Neo Avg Total Comp Amt
IMMUNOVANT, INC. (IMVT) reported Non Peo Neo Avg Total Comp Amt of $4.09 million for the 12-month period ending 2026-03-31, per its DEF 14A filed 2026-07-22.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-07-22
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2026-03-31 | $4.09M DEF 14A · filed 2026-07-22 |
| 2025-03-31 | $4.89M DEF 14A · filed 2026-07-22 |
| 2024-03-31 | $3.87M DEF 14A · filed 2026-07-22 |
| 2023-03-31 | $1.99M DEF 14A · filed 2026-07-22 |
| 2022-03-31 | $5.63M DEF 14A · filed 2026-07-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |